Evexia Lifecare Ltd
EVEXIA.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.96B
Close$
$-0.89
142.2% downside
Current Fair Value
142.2% downsideOvervalued by 142.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.96 Billion |
|---|---|
| Enterprise Value | $3.97 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.01 |
| Beta | 1.52 |
| Outstanding Shares | 1,877,328,995 |
Return
| Return on Equity | 0.43% |
|---|---|
| Return on Assets | 0.21% |
| Return on Invested Capital | 0.25% |
Valuation & Multiples
| P/E Ratio | 215.31 |
|---|---|
| PEG | -635.7 |
| Price to Sales | - |
| Price to Book Ratio | 1.06 |
| Enterprise Value to Revenue | 3.34 |
| Enterprise Value to EBIT | 201.4 |
| Enterprise Value to Net Income | 212 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Evexia Lifecare Ltd
9 employees
CEO: Jayesh Raichandbhai Thakkar Evexia Lifecare Limited, formerly known as Kavit Industries Limited, primarily trades pharmaceutical chemicals in India. The company also manufactures petrochemical downstream products like special oils, chemicals, petroleum sulphates, and solvents for various industrial applications.